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Optimisation of growth hormone secretagogues
A number of peptidic compounds have been discovered that have the ability to release growth
hormone (GH) from the pituitary. Through this mechanism these agents may offer the
opportunity to treat a number of medical conditions including GH deficiency, osteoporosis and
obesity. A number of acylated dipeptides related to ipamorelin (i) have been investigated as
GH releasers, and a recent paper describes the use of combinatorial chemistry to investigate
SAR in this series (Demonstration of the strength of focused combinatorial libraries in SAR
optimisation of growth hormone secretagogues, M. Ankersen et al., Eur. J. Med. Chem., 34,
(1999), 783-790).
The 96 compounds in the library were individually synthesised on an N-methylated amine
solid-phase support in a fashion that allowed variation of three positions of diversity (ii) and
the generation of a terminal N-methylamide following trifluoroacetic acid-catalysed cleavage.
The in vitro GH releasing properties of the purified products were determined in a rat pituitary
cell assay, and full agonist potencies with EC50 values down to 1 nM were observed. It was
notable that there was a distinct unpredictability in the SAR, in that some building blocks did
not confer activity in a predictable manner. This very unpredictability emphasises the
advantages of making every compound in the combinatorial library, rather than relying on
isolated compounds to develop the SAR.
--------------------------------------------------------------------------------------------------------------
Neurokinin-3 receptor antagonist SAR
The neurokinin-3 receptor is one of three receptors that binds the tachykinin or neurokinin
family of peptides. A number of non-peptide antagonists of the human receptor have been
reported, and the use of combinatorial chemistry to optimise the antagonist, SR 142801 (iii)
has recently been disclosed (Investigation of SAR requirements of SR 142801 through an
indexed combinatorial library in solution, L.F. Raveglia et al., Eur. J. Med. Chem., 34, (1999),
825-835).
The 3-(3,4-dichlorophenyl)-3-propylpiperidine fragment was held constant whilst the amine
and acylating group substituents were varied in an indexed (or orthoganol) combinatorial
library. In total 49 compounds were prepared using solution phase methods in orthoganol
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pools of seven compounds. By screening the compounds whilst in these mixtures it was
possible to identify which of the peripheral groups made the greatest contribution to receptor
affinity. These predictions were confirmed by the preparation and testing of six individual
compounds, although the best compound discovered from this approach was still around 30-
fold weaker than SR 142801.
----------------------------------------------------------------------------------------------------------
Inhibitors of inducible NOS
The inducible form of nitric oxide synthase (iNOS) is implicated in a variety of inflammatory
and autoimmune diseases including septic shock, rheumatoid arthritis, osteoarthritis and
multiple sclerosis. The reactive nitric oxide (NO) gives rise to non specific tissue damage and
thus selective inhibitors of iNOS may have a place in the pharmacological therapy of these
conditions. The use of combinatorial chemistry in the discovery of novel inhibitors of the
dimerization of iNOS monomers is described in a recent paper (Allosteric inhibitors of
inducible nitric oxide synthase dimerization discovered via combinatorial chemistry, K.
McMillan et al., Proc. Natl. Acad. Sci. USA., 97, (2000), 1506-1511).
A library of 8,649 pyrimidineimidazoles was prepared in an encoded form on a polyethylene
glycol grafted polystyrene support. The identity of each compound was recorded by the
simultaneous addition of encoding polyhalogenated phenyl ethers attached to the resin bead by
oxidatively cleavable linkers. One compound (iv) from the library was found to be a potent
inhibitor of the dimerization of the iNOS monomers and furthermore was shown to have high
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selectivity over endothelial NOS essential for maintaining vascular homeostasis. The crystal
structure of the inhibitor-monomer complex revealed that the inhibitor binds to the heme
moiety and distorts the structural features necessary for formation of the stable and active
dimer.
 2000 Elsevier Science Ltd. All rights reserved.
